Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002048 |
---|---|
Receipt number | R000002265 |
Scientific Title | Evaluation study of diagnostic efficacy in malignant tumors using 11C-methionine PET/CT |
Date of disclosure of the study information | 2009/06/06 |
Last modified on | 2019/04/01 12:42:36 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/06/05 09:16:32 | ||
2 | Update | 2012/12/05 18:51:12 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
3 | Update | 2015/07/06 08:11:49 | UMIN ID1 |
|
4 | Update | 2016/05/30 10:54:14 | Division name Organization Name of person sending information Division name Division name Address Address TEL Name of primary person or sponsor Department Organization Organization Organization Division Category of Funding Organization Nationality of Funding Organization Nationality of Funding Organization Institutions |
|
5 | Update | 2016/05/30 11:02:21 | Last follow-up date Results |
|
6 | Update | 2016/06/06 08:48:36 | Target sample size |
|
7 | Update | 2016/06/06 08:50:16 | Last follow-up date |
|
8 | Update | 2017/12/11 09:13:52 | Recruitment status Last follow-up date Date analysis concluded Results |
|
9 | Update | 2018/06/11 09:25:01 | Division name |
|
10 | Update | 2018/06/11 09:37:27 | Name of primary person or sponsor Institute Organization Organization |
|
11 | Update | 2018/12/12 09:37:10 | Results |
|
12 | Update | 2019/04/01 11:27:29 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code TEL Last name of contact person Last name of contact person Zip code TEL Name of person sending information Organization Organization Address Address Tel |
|
13 | Update | 2019/04/01 11:34:34 | Recruitment status Date of IRB Last follow-up date |
|
14 | Update | 2019/04/01 12:33:32 | TEL |
|
15 | Update | 2019/04/01 12:42:36 | Number of participants that the trial has enrolled Results |